This page shows the latest Aspen news and features for those working in and with pharma, biotech and healthcare.
In the ASPEN trial, Brukinsa hit higher rates of CR and VGPR compared to Imbruvica – 28.9% of relapsed or refractory patients compared to 19.8%.
The acquisition will include shares in Aspen Japan K.K. and all associated assets held by AGI. ... The proceeds Aspen gains from the transaction will be used to reduce its debts.
In August, Aspen admitted that it had took part in the arrangement, but the other two companies implicated have made no admission. ... This acquisition made Aspen the sole owner of all existing fludrocortisone marketing authorisations in the UK.
Other Gold winners included Aspen, Boeringher Ingelheim, Galderma, Johnson &Johnson, Mundipharma, Napp, Novartis, PTC Therapeutics, Shire, Teva, Tillotts Pharma and ViiV. ... Target Award for Corporate Communications: Ogilvy Healthworld for Boehringer
This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood
Amid reports of price increases of several hundred per cent. Aspen Pharmacare is under investigation by the EU's competition authorities over its pricing of five cancer medicines, amid allegations of ... The five generic medicines - chlorambucil,
More from news
Approximately 9 fully matching, plus 21 partially matching documents found.
based on the allegation that Aspen had paid these competitors to not enter the market. ... In a landmark move, and as the direct product of the investigation, Aspen approached the CMA with an unprecedented settlement offer.
She has been creative in the way she pushed the boundaries of the treaties with, for example, the pricing investigation over Aspen Pharma.
$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014.
Reflecting a long standing business relationship, Aspen paid GSK £180m to acquire Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to £100m in milestone payments. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva,
Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘BRIC’ markets (Brazil,
Address:. Aspen Farm. Sheep Lane Woburn. Bedfordshire. MK17 9HD. UK.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...